Market News AIOpen the app

KNSA stock news · Kiniksa Pharmaceuticals International

Stories about Kiniksa Pharmaceuticals International (KNSA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for KNSA

Follow Kiniksa Pharmaceuticals International (KNSA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for KNSA
Free on the App Store and Google Play, or on the web.
  1. Nov 6, 2026, 6:16 PM ET · Market

    An insider at Kiniksa Pharmaceuticals sold shares for $14,330,278.

    Neutral

    Kiniksa's insider sale totaled $14,330,278. The report gives no seller identity or reason, so the sale alone does not change the company's outlook.